Similar Search Results

The national regulation of pharmaceutical markets and the timing of new drug launches in Europe

Heuer, Alexander (contributor); Mejer, Malwina (contributor) - 2007

the EMEA's centralized procedure. We find that direct price control regimes have a significantly negative impact on the … launch timing. These results cannot be found when investigating the impact of indirect price controls. Our results show that … countries (18% for Portugal and 19% for Greece). This difference accrues from both price regulation and market attractiveness …

Persistent link: https://www.econbiz.de/10003471161

Health care expenditure and the state of health care sector in selected European Union countries

Hady, Joanna; Leśniowska, Małgorzata - In: E-Finanse : finansowy kwartalnik internetowy 7 (2011) 4, pp. 25-36

The article deals with the issue of health care, focusing on expenditure allocated to it. The first part of the article reviews some selected European Union countries, analyzing their expenditure on their health care sectors. The second part brings an analysis of expenditure on health care in...

Persistent link: https://www.econbiz.de/10009511407

Parallel trade and reimbursement regulation

Birg, Laura - 2015

This paper studies interaction of pharmaceutical regulation and parallel trade in a North-South framework. An innovative Örm located in the North can sell its drug only in the North or in both countries. Governments may limit reimbursement for the drug. Reimbursement limits reduce the Örmís...

Persistent link: https://www.econbiz.de/10011290061

Pharmaceutical regulation at the wholesale level and parallel trade

Birg, Laura - 2013

This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by parallel trade, i.e. trade outside the manufacturerś authorized distribution channel. In particular, maximum wholesale margins, a restriction of pricing by the intermediary, and...

Persistent link: https://www.econbiz.de/10010223101

Patient mobility, health care quality and welfare

Brekke, Kurt R.; Levaggi, Rosella; Siciliani, Luigi; … - 2014

Patient mobility is a key issue in the EU who recently passed a new law on patients' right to EU-wide provider choice. In this paper we use a Hotelling model with two regions that differ in technology to study the impact of patient mobility on health care quality, health care financing and...

Persistent link: https://www.econbiz.de/10010229860

Pharmaceuticals : Access, Cost, Pricing, and Directions for the Future

Danzon, Patricia M. - 2011

Prescription drug expenditures make up less than 10 percent of total personal health care expenditures in the United States, but over the last decade the amount that Americans spend on prescription drugs has grown much faster than any other component of personal health care. For example, between...

Persistent link: https://www.econbiz.de/10013126058

The Future of Long Term Care in Europe. An Investigation Using a Dynamic Microsimulation Model

Atella, Vincenzo - 2017

In this paper we investigate the evolution of public European LTC systems in the forthcoming decades, using the Europe Future Elderly Model (EuFEM), a dynamic microsimulation model which projects the health and socio-economic characteristics of the 50 population of ten European countries,...

Persistent link: https://www.econbiz.de/10012956880

Price Caps versus Reimbursement Limits : Pharmaceutical Regulation under Market Integration through Parallel Trade

Birg, Laura - 2019

. Governments in both countries may limit prices directly via price caps or restrict third-party payer reimbursement for the drug … price cap and a reimbursement limit under certain conditions. In the destination country, parallel trade has no effect on … the level of regulation under a price cap, and it intensies regulation under a reimbursement limit.Parallel trade may …

Persistent link: https://www.econbiz.de/10012889817

Excessive Pharmaceutical Prices and Competition Law : Doctrinal Development to Protect Public Health

Abbott, Frederick M. - 2017

Persistent link: https://www.econbiz.de/10012970248

Regulated Competition on Health Insurance Markets : Budget Balancing, Opt-out and Price Caps

Schickner, Benjamin - 2017

This paper studies redistributional effects of competition between private and public insurance on health insurance markets based on the example of Germany. Health insurance is provided by a budget-balancing public insurance and a revenue-maximizing private insurance; customers are characterized...

Persistent link: https://www.econbiz.de/10012970738

1
2
3
4
5
6
7
8
9
10
Next
Last